IRhythm plans Zio MCT FDA filing in 2027 while raising 2026 revenue outlook to $890M-$895M
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
Gold drifts lower as rebounding bond yields and Fed hike bets support USD ahead of US NFP
Gold (XAU/USD) attracts fresh sellers after failing to find acceptance above the $4,100 mark during the Asian session on Friday, extending the previous day's retracement slide from a two-week high.
Brent crude tops $100, WTI nears $92 amid fresh Strait of Hormuz attacks
Fresh maritime security concerns in a key global oil transit route lifted crude futures, while regional diplomatic efforts continued to stabilise tensions.
Kimberly-Clark vs. Lululemon Athletica: Which Consumer Goods Stock Is a Better Buy for 2027?
Key PointsKimberly-Clark maintains a defensive position with essential household brands and steady cash generation.
AISTA seeks 35% hike in minimum selling price of sugar to Rs 42/kg , backs government cane FRP
AISTA has urged the government to raise the minimum selling price of sugar amid ongoing protests by farmers. The association supports the current fair and remunerative price for sugarcane set for the…